About: http://webisa.webdatacommons.org/125420579

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Sorafenib is a well-tolerated oral multi-kinase inhibitor with potent antiangiogenic activity.
http://www.w3.org/ns/prov#wasQuotedFrom	abstractsonline.com